These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3258879)

  • 21. Thymic stroma-derived T-cell inhibitory factor (TSTIF). 2: TSTIF acts on the antigen-presenting cell to inhibit antigen-stimulated T-cell proliferation.
    Tai XG; Kita Y; Toyooka K; Hamaoka T; Fujiwara H
    Thymus; 1993 Jun; 21(4):247-58. PubMed ID: 8284807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
    Milich DR; Louie RE; Chisari FV
    J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
    González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
    Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A change in antigen presentation ability of spleen macrophage from Balb/c mouse during late pregnancy].
    Tan Z; Li S; Cao Z; Zhao Z; Ma Q; Huang Z; Li L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):674-7. PubMed ID: 14619578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accessory cell stimulation of T cell proliferation requires active antigen processing, Ia-restricted antigen presentation, and a separate nonspecific 2nd signal.
    Germain RN
    J Immunol; 1981 Nov; 127(5):1964-6. PubMed ID: 6170681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
    de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
    J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells.
    Ullrich SE
    J Immunol; 1994 Apr; 152(7):3410-6. PubMed ID: 8144924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cationization of protein antigens. V. Effect of the degree of cationization on patterns of immune responsiveness.
    Muckerheide A; Pesce AJ; Michael JG
    Cell Immunol; 1990 Apr; 127(1):67-77. PubMed ID: 1690611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.
    Kleijmeer MJ; Ossevoort MA; van Veen CJ; van Hellemond JJ; Neefjes JJ; Kast WM; Melief CJ; Geuze HJ
    J Immunol; 1995 Jun; 154(11):5715-24. PubMed ID: 7751623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation-induced death of antigen-specific CD4+ T lymphocytes.
    Damle NK; Klussman K; Leytze G; Aruffo A; Linsley PS; Ledbetter JA
    J Immunol; 1993 Sep; 151(5):2368-79. PubMed ID: 7689606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein synthesis in antigen processing.
    Jensen PE
    J Immunol; 1988 Oct; 141(8):2545-50. PubMed ID: 3049813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.